Description

These vials are pure FOX04DRI API (Active Pharmaceutical Ingredeint). no fillers not lypholized (freeze dried)

FOXO4-DRI (FOXO4 D-Retro-Inverso Peptide) is a senolytic research peptide developed to selectively target senescent cells—damaged or aged cells that no longer function properly but resist natural cellular removal. These cells can accumulate over time and contribute to chronic inflammation, tissue dysfunction, reduced recovery capacity, and visible signs of aging.
FOXO4-DRI works by disrupting the interaction between FOXO4 and p53 within senescent cells, promoting apoptosis (programmed cell death) specifically in those dysfunctional cells while allowing healthier cells to remain intact.

By helping clear senescent cell accumulation, FOXO4-DRI is being researched for its potential role in longevity, tissue regeneration, recovery optimization, and overall cellular health.

Researchers and biohackers commonly explore FOXO4-DRI in protocols focused on healthy aging, inflammation management, performance recovery, and cellular rejuvenation. Interest in the peptide has continued to grow due to its unique senolytic mechanism and potential to support healthier cellular environments.